Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Double-blind comparison of VAC BNO 1095 FCT vs placebo in cyclic mastodynia and premenstrual syndrome
2010-021036-33Phase 3Completed
- Sponsor
- Bionorica
- Start
- Jan 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of cyclodynon in cyclical mastalgia and premenstrual syndrome (PMS) (3 arms), sponsored by Bionorica. Primary endpoint: Change in maximum severity of cyclic breast pain. Started Jan 2011; status: completed.
02
Drugs
cyclodynon
03
Conditions
cyclical mastalgiapremenstrual syndrome (PMS)
Beyond the preview
Go deeper on 2010-021036-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-021036-33.